logo-loader
RNS
viewSophos Group PLC

Sophos Group Plc - Scheme Timetable Update

RNS Number : 3845E
Sophos Group Plc
27 February 2020
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

FOR IMMEDIATE RELEASE

27 February 2020

RECOMMENDED CASH ACQUISITION

of

SOPHOS GROUP plc

by

SURF BUYER LIMITED

(a newly formed company owned by FUNDS MANAGED aND/OR ADVISED BY THOMA BRAVO, LLC)  

to be effected by means of a Scheme of Arrangement under
Part 26 of the Companies Act 2006

TIMETABLE UPDATE

On 14 October 2019, the boards of Sophos Group PLC ("Sophos") and Surf Buyer Limited, a newly formed company owned by funds managed and/or advised by Thoma Bravo, LLC ("Bidco") announced the terms of a recommended cash offer pursuant to which Bidco will acquire the entire issued and to be issued share capital of Sophos (the "Acquisition") to be effected by means of a Court-sanctioned scheme of arrangement under Part 26 of the Companies Act (the "Scheme"). The circular in relation to the Scheme (the "Scheme Document") was posted to Sophos Shareholders on 8 November 2019.

On 25 February 2020, Sophos announced that the High Court of Justice in England and Wales (the "Court") had sanctioned the Scheme and that the Scheme was expected to become Effective, and Sophos Shares suspended from trading, on 27 February 2020.


Further to the announcement made by Sophos on 26 February 2020 regarding the delay to the timetable to allow Sophos and Bidco the opportunity to discuss with the UK Financial Conduct Authority (the "FCA") the status of a limited permission held by a subsidiary of Sophos, Sophos and Bidco are pleased to announce that the FCA has approved the cancellation of Sophos' permission, which is no longer required for the operation of Sophos' business. 

The Acquisition therefore remains subject only to the delivery of a copy of the Court Order to the Registrar of Companies. Delivery, and therefore the Effective Date, is expected to take place on 2 March 2020.

Applications have been made for the suspension of trading in Sophos Shares on the London Stock Exchange's main market for listed securities and the listing of Sophos Shares on the premium listing segment of the Official List of the Financial Conduct Authority and such suspensions are expected to take effect from 7:30 a.m. on 2 March 2020. The last day of dealings in, and for the registration and transfer of, the Sophos Shares will be 28 February 2020. The de-listing of Sophos Shares from the premium listing segment of the Official List of the Financial Conduct Authority and the cancellation of the admission to trading of Shares on the London Stock Exchange's main market for listed securities have also been applied for and will, subject to the Scheme becoming effective, take effect at 8 a.m. (London time) on 3 March 2020.

All valid elections made pursuant to the Currency Election facility prior to the Election Return Time remain valid.

Effective Date and Timetable

The revised timetable of principal events for the implementation of the Scheme is set out below. If any change to the key dates and/or times set out in the timetable are made, Sophos and Bidco will give notice of this change by issuing an announcement through a Regulatory Information Service and by making such announcement available on Sophos' website at https://investors.sophos.com.

Event

Time and/or date(1)

Last day for dealings in, and for the registration of transfers of, Sophos Shares

Scheme Record Time

Disablement of CREST in respect of Sophos Shares

Suspension of dealings in Sophos Shares

Effective Date of the Scheme

Cancellation of listing of Sophos Shares

Latest date for despatch of cheques and crediting of CREST accounts for cash consideration due under the Scheme

Long Stop Date

28 February 2020

8.00 p.m. on 28 February 2020

8.00 p.m. on 28 February 2020

By 7.30 a.m. on 2 March 2020

2 March 2020

8 a.m. on 3 March 2020

16 March 2020



26 June 2020(2)

 

Note:

(1)   All references in this announcement to times are to London, United Kingdom time unless otherwise stated.

(2)   This is the latest date by which the Scheme may become effective. However, the Long Stop Date may be extended to such later date as Sophos and Bidco may agree in writing (with the Panel's consent and as the Court may approve (if such consent and/or approval is/are required)).

Capitalised terms used but not defined in this announcement have the meanings given to them in the Scheme Document.


Enquiries:

Sophos Group plc
Kris Hagerman, Chief Executive Officer
Derek Brown, Vice President Investor Relations

Tel: +44 (0) 12 3555 9933

 

Tulchan Communications (financial PR adviser to Sophos)
James Macey White
Matt Low

Tel: +44 (0)20 7353 4200

 

J.P. Morgan Cazenove (lead financial adviser and corporate broker to Sophos)

Gary Weiss
Bill Hutchings
James Robinson
Chris Wood

Tel: +44 (0)20 7742 4000

Lazard (financial adviser and Rule 3 adviser to Sophos)

Cyrus Kapadia
Philippe Noël

Tel: +44 (0)20 7187 2000

UBS AG London Branch (corporate broker and financial adviser to Sophos)
Jonathan Rowley
David Roberts

Tel: +44 (0)20 7567 8000

Finsbury (PR adviser to Bidco and Thoma Bravo)
Faeth Birch
Edward Simpkins

Tel: +44 (0)20 7251 3801

 

Goldman Sachs (financial adviser to Bidco and Thoma Bravo)
Ward Waltemath
Mark Sorrell
Chris Emmerson
Jimmy Bastock (Corporate Broking)



Tel: +1 212 902 1000
Tel: +44 (0)20 7774 1000
Tel: +44 (0)20 7774 1000
Tel: +44 (0)20 7774 1000

Important notices


Goldman Sachs International, which is authorised by the PRA and regulated by the FCA and the PRA in the United Kingdom, and Goldman Sachs & Co. LLC (together, "Goldman Sachs") are acting exclusively for Bidco and Thoma Bravo as financial advisers and no one else in connection with the Acquisition, this announcement or any matter referred to herein and will not be responsible to anyone other than Bidco and Thoma Bravo for providing the protections afforded to clients of Goldman Sachs, nor for providing advice in connection with the Acquisition, this announcement or any matter referred to herein. Neither Goldman Sachs nor any of Goldman Sachs' subsidiaries, affiliates or branches owes or accepts any duty, liability or responsibility whatsoever (whether direct, indirect, consequential, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Goldman Sachs in connection with the Acquisition, this announcement, any matter referred to herein or otherwise.

J.P. Morgan Securities plc, which conducts its UK investment banking business as J.P. Morgan Cazenove ("J.P. Morgan Cazenove"), is authorised in the United Kingdom by the PRA and regulated by the PRA and the FCA. J.P. Morgan Cazenove is acting as financial adviser exclusively for Sophos and no one else in connection with the Acquisition and will not regard any other person as its client in relation to the Acquisition and will not be responsible to anyone other than Sophos for providing the protections afforded to clients of J.P. Morgan Cazenove or its affiliates, or for providing advice in relation to the Acquisition or any other matter or arrangement referred to herein.

Lazard & Co., Limited ("Lazard"), which is authorised and regulated by the FCA in the United Kingdom, is acting exclusively as financial adviser to Sophos and no one else in connection with the Acquisition and will not be responsible to anyone other than Sophos for providing the protections afforded to clients of Lazard nor for providing advice in connection with the Acquisition or any other matter referred to herein. Neither Lazard nor any of its affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Lazard in connection with the Acquisition, any statement contained herein or otherwise.

UBS AG London Branch ("UBS") is authorised and regulated by the Financial Market Supervisory Authority in Switzerland. It is authorised by the PRA and subject to regulation by the FCA and limited regulation by the PRA in the United Kingdom. UBS is acting exclusively as financial adviser to Sophos and no one else for the purpose of the Acquisition and will not be responsible to anyone other than Sophos for providing the protections offered to clients of UBS nor for providing advice in relation to the Acquisition or any transaction, arrangement or other matter referred to herein.

In accordance with the Takeover Code, Goldman Sachs International, J.P. Morgan Cazenove and UBS and their respective affiliates will continue to act as exempt principal trader in Sophos securities on the London Stock Exchange. These purchases and activities by exempt principal traders which are required to be made public in the United Kingdom pursuant to the Takeover Code will be reported to a Regulatory Information Service and will be available on the London Stock Exchange website at www.londonstockexchange.com. This information will also be publicly disclosed in the United States to the extent that such information is made public in the United Kingdom.

Further information

This announcement is for information purposes only and is not intended to, and does not, constitute or form part of any offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction pursuant to the Acquisition or otherwise nor shall there be any sale, issuance or transfer of securities of Sophos in any jurisdiction in contravention of applicable law. The Acquisition will be implemented solely pursuant to the terms of the Scheme Document (or, if the Acquisition is implemented by way of an Offer, the Offer Document), which contains the full terms and conditions of the Acquisition.  Each Shareholder is urged to consult his independent professional adviser immediately regarding the tax consequences of the Acquisition applicable to him.

This announcement does not constitute a prospectus or prospectus equivalent document.

Overseas Shareholders

This announcement has been prepared in accordance with English law, the Takeover Code, the Market Abuse Regulation, the Listing Rules and the Disclosure Guidance and Transparency Rules and information disclosed may not be the same as that which would have been prepared in accordance with the laws of jurisdictions outside England.

The availability of the Acquisition to Sophos Shareholders who are not resident in and citizens of the UK may be affected by the laws of the relevant jurisdictions in which they are located or of which they are citizens. It is the responsibility of any person outside the United Kingdom into whose possession this announcement comes to satisfy themselves as to the full observance of the laws of the relevant jurisdiction in connection with the Acquisition, including the obtaining of any governmental, exchange control or other consents which may be required and/or compliance with other necessary formalities which are required to be observed and the payment of any issue, transfer or other taxes or levies due in such jurisdiction. The release, publication or distribution of this announcement in certain jurisdictions may be restricted by law. Persons who are not resident in the UK should inform themselves of, and observe, any applicable legal or regulatory requirements of their jurisdictions. Any failure to comply with the applicable restrictions may constitute a violation of the securities laws of any such jurisdiction. To the fullest extent permitted by applicable law, the companies and persons involved in the Acquisition disclaim any responsibility or liability for the violation of such restrictions by any person.

This announcement does not constitute an offer to sell or issue or the solicitation of an offer to buy or subscribe for shares in any jurisdiction in which such offer or solicitation is unlawful.

The receipt of cash pursuant to the Acquisition by a US holder of Sophos Shares as consideration for the transfer of its Sophos Shares pursuant to the Scheme will be a taxable transaction for US federal income tax purposes and may also be a taxable transaction under applicable state and local tax laws, as well as foreign and other tax laws. Each US holder of Sophos Shares is strongly advised to consult an appropriately qualified independent professional tax adviser immediately with respect to the tax consequences of the Scheme.

Overseas shareholders should consult their own legal and tax advisers with respect to the legal and tax consequences of the Scheme.

Publication on a website

This announcement will be made available on the Sophos website at https://investors.sophos.com promptly and in any event by no later than 12:00 p.m. on the Business Day following the date of this announcement. For the avoidance of doubt, the content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
OUPEADAXAELEEFA

Quick facts: Sophos Group PLC

Price: -

Market: LSE
Market Cap: -
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE